NCT07524400 Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease
| NCT ID | NCT07524400 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad Rey Juan Carlos |
| Condition | Parkinson' Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-05-10 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-05-10 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A controlled, blinded, and randomized clinical study will be carried out in a large sample of people with Parkinson's disease, where the combined effects of physical exercise and transcranial direct curren stimlation (tDCS) on motor function will be evaluated.
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of idiopathic Parkinson's disease, established according to the UK Parkinson's Disease Society Brain Bank Criteria. Ability to understand and comply with study procedures. Stable antiparkinsonian medication regimen prior to study participation. Exclusion Criteria: Significant cognitive impairment, defined as a score \< 23 on the Mini-Mental State Examination (MMSE). Below-average premorbid intelligence, defined as a score \< 40 on the Vocabulary subtest of the Wechsler Adult Intelligence Scale - Third Edition (WAIS-III). Clinically significant depression, defined as a score \> 10 on the Geriatric Depression Scale (GDS-15). Current treatment with cholinesterase inhibitors. Presence of severe cardiovascular disease, including but not limited to: Congestive heart failure Ischemic heart disease Cardiac pacemaker Orthostatic hypotension Uncontrolled diabetes mellitus. History of stroke or traumatic brain injury. History of seizure disorder or epilepsy. Presence or prior implantation of a deep brain stimulation (DBS) device. History of major orthopedic surgery that could interfere with motor performance or gait. Presence of implanted electronic devices, including cardiac pacemakers, incompatible with study procedures.
Contact & Investigator
Miguel Angel Fernández del Olmo, PhD
PRINCIPAL INVESTIGATOR
Universidad Rey Juan Carlos
Frequently Asked Questions
Who can join the NCT07524400 clinical trial?
This trial is open to participants of all sexes, studying Parkinson' Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07524400 currently recruiting?
Yes, NCT07524400 is actively recruiting participants. Contact the research team at eduardo.villamil@urjc.es for enrollment information.
Where is the NCT07524400 trial being conducted?
This trial is being conducted at Fuenlabrada, Spain.
Who is sponsoring the NCT07524400 clinical trial?
NCT07524400 is sponsored by Universidad Rey Juan Carlos. The principal investigator is Miguel Angel Fernández del Olmo, PhD at Universidad Rey Juan Carlos. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.